U.S., Sept. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07818499) titled 'A Study of BL-M08D1 in Combination With Immunochemotherapy in Patients With Diffuse Large B-Cell Lymphoma' on Sept. 08.
Brief Summary: This Phase Ib/II study is a clinical trial to explore the efficacy and safety of BL-M08D1 for injection in combination with immunochemotherapy in patients with diffuse large B-cell lymphoma.
Study Start Date: Sept., 2026
Study Type: INTERVENTIONAL
Condition:
Diffuse Large B-Cell Lymphoma
Intervention:
DRUG: BL-M08D1
Administration by intravenous infusion for a cycle of 3 weeks.
DRUG: Rituximab
Administration by intravenous infusion for a cycle of 3 weeks.
DRUG: Gemcitabine Hydrochloride
A...